Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jiangxi Juwang Pharmaceutical Co., Ltd. is a Chinese pharmaceutical company and a wholly-owned subsidiary of Jiangxi Yintao Pharmaceutical Co., Ltd. Based in Nanfeng County, Jiangxi Province, the company specializes in the research, development, and manufacturing of traditional Chinese medicines (TCM) and chemical drugs. Its product portfolio includes treatments for urogenital, cardiovascular, and respiratory conditions, with its lead candidate, Yanli Capsule, currently in Phase 2 clinical trials for erectile dysfunction. The company operates multiple GMP-compliant production lines and is recognized as a high-tech enterprise in Jiangxi Province. It leverages the R&D capabilities of its parent company and the Jiangxi Provincial Institute of Traditional Chinese Medicine to develop innovative herbal therapies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jiangxi Juwang Pharmaceutical.